These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6691455)

  • 1. Response to antipsychotic medication: the doctor's and the consumer's view.
    Van Putten T; May PR; Marder SR
    Am J Psychiatry; 1984 Jan; 141(1):16-9. PubMed ID: 6691455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective response to antipsychotic drugs.
    Van Putten T; May PR; Marder SR; Wittmann LA
    Arch Gen Psychiatry; 1981 Feb; 38(2):187-90. PubMed ID: 7212946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akathisia with haloperidol and thiothixene.
    Van Putten T; May PR; Marder SR
    Arch Gen Psychiatry; 1984 Nov; 41(11):1036-9. PubMed ID: 6497564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol and thiothixene in the long-term treatment of chronic schizophrenic outpatients in an urban community: social and vocational adjustment.
    Engelhardt DM; Rudorfer L; Rosen B
    J Clin Psychiatry; 1978 Dec; 39(12):834-40. PubMed ID: 721787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol for chronically hospitalized psychotics: a double-blind comparison with thiothixene and placebo; a follow-up open evaluation.
    Howard JS
    Dis Nerv Syst; 1974 Oct; 35(10):458-63. PubMed ID: 17894059
    [No Abstract]   [Full Text] [Related]  

  • 7. Risperidone in treatment-refractory schizophrenia.
    Wirshing DA; Marshall BD; Green MF; Mintz J; Marder SR; Wirshing WC
    Am J Psychiatry; 1999 Sep; 156(9):1374-9. PubMed ID: 10484947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative efficacy of parenteral haloperidol and thiothixene for the emergency treatment of acutely excited and agitated patients.
    Stotsky BA
    Dis Nerv Syst; 1977 Dec; 38(12):967-73. PubMed ID: 338270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone.
    Seemüller F; Lewitzka U; Bauer M; Meyer S; Musil R; Schennach R; Riedel M; Doucette S; Möller HJ
    Pharmacopsychiatry; 2012 Nov; 45(7):292-6. PubMed ID: 22614116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and differential diagnosis of depressive syndromes in schizophrenia.
    Martin RL; Cloninger CR; Guze SB; Clayton PJ
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):9-13. PubMed ID: 2865255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement.
    Bartkó G; Herczeg I; Békésy M
    J Clin Psychiatry; 1987 Sep; 48(9):363-5. PubMed ID: 3624207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol.
    Kim JH; Byun HJ
    J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid tranquilization: a comparative study of thiothixene and haloperidol.
    Kelwala S; Ban TA; Berney SA; Wilson WH
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):77-83. PubMed ID: 6145189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K; Okada M
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
    Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
    J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of thiothixene on schizophrenic symptoms in a long-term therapeutic scheme. Comparative study with butyrophenone derivative].
    Vianna Filho U; Muniz AF; Terra SO; Bueno JR
    J Bras Psiquiatr; 1971; 20(3):193-204. PubMed ID: 5164436
    [No Abstract]   [Full Text] [Related]  

  • 17. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
    Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
    Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
    Dufresne RL; Wagner RL
    J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once versus thrice daily thiothixene in the treatment of schizophrenic in-patients.
    Lee JH; Branchey M; Haher EJ; Varga E; Simpson GM
    Br J Psychiatry; 1974 Jul; 125(0):73-8. PubMed ID: 4604854
    [No Abstract]   [Full Text] [Related]  

  • 20. Subjective response to neuroleptics in schizophrenia.
    Awad AG
    Schizophr Bull; 1993; 19(3):609-18. PubMed ID: 7901897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.